An $80 million national research plan to attack Alzheimer’s, a mind-robbing malady that may affect as many as 16 million Americans by 2050, will start this year with U.S.-sponsored studies on ways to prevent the disease in high- risk people, and treat it with an insulin nasal spray. The goal, to develop new treatments by 2025, faces tough challenges, said Ronald Petersen, a researcher at the Mayo Clinic in Rochester, Minnesota.
Bloomberg by Shannon Pettypiece
Tags: alzheimer's disease, Bloomberg, Dr. Ronald Petersen, insulin nasal spray, Mayo Clinic Rochester, Research